Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regenicin, Inc. (RGIN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +6.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +6.3%, free cash flow -13.2% with operating margin 0.0% and ROIC 12.1%. Stock Foundry combines RGIN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RGIN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RGIN Max Drawdown
-80.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RGIN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$559.0K
+26.3% YoY
Free Cash Flow
-$133.7K
-5.4% YoY
Revenue Growth
+0.0%
EPS Growth
+6.3%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -601K | 0 | 0 | 0 | 0 |
| Operating Income | -601K | -636K | -511K | -737K | -540K |
| EBITDA | -601K | -636K | -511K | -737K | -789K |
| Net Income | -639K | -671K | -560K | -758K | -559K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15K | 2K | 1K | 815 | 3K |
| Total Assets | 15K | 5K | 4K | 5K | 56K |
| Total Liabilities | 6M | 5M | 4M | 4M | 3M |
| Shareholder Equity | -6M | -5M | -4M | -4M | -3M |
| Total Debt | 643K | 603K | 578K | 455K | 213K |
| Net Debt | 628K | 601K | 577K | 454K | 210K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
134K
-5.4% YoY
Capital Expenditures
0
Free Cash Flow
134K
-5.4% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
11.9%
Debt / Equity
-0.11x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.